In the present report two distinct but aligned areas of investigation pursued in this and other laboratories are reviewed. In the first, the experimental production of hetero-, iso-, and autoantibodies to prostatic and other accessory glands tissues of reproduction of man, monkey, canine, and rabbit have been employed to study the immunologic properties of these tissues and their possible immunopathogenicity as related to diseases of the prostate in man. In the second, the results of the experimental aspects of prostatic cryosurgery leading to the successful adaptation of the therapeutic utilization of cryosurgery for the destruction of benign and malignant prostatic tissue, particularly in the treatment of the elderly and in cases presently not amenable to the conventional methods of prostatic surgery, are presented. The possible production of an ‘immuno-cryothermic’ response to freezing and refreezing the primary prostatic tumour in cases of metastasizing adenocarcinoma of the prostate as observed by the remission of metastatic lesions in six patients so treated, possibly presents an entirely new approach to the treatment of malignant diseases through the in situ immunization of the host to his own tumour.

This content is only available via PDF.
© 1970 S. Karger AG, Basel
1970
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.